Mayank Jain

Mayank Jain is a seasoned finance professional currently serving as the CFO for EMEA at Novartis Gene Therapies. With over 15 years of experience in finance, they have held various roles in major companies, including Deputy Reporting Lead and Reporting Lead at Novartis. Mayank previously worked at PricewaterhouseCoopers and Manhattan Associates, among others, and has a strong background in financial planning and data analysis. They hold an MBA in finance from the Indian School of Business and a bachelor’s degree in mechanical engineering from the Indian Institute of Technology, Delhi. Mayank is committed to leveraging their financial expertise to support the commercialization of new treatments in healthcare.